Literature DB >> 7970084

Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1 alpha (IL-1 alpha) and other cytokines.

R N Boswell1, B A Yard, E Schrama, L A van Es, M R Daha, F J van der Woude.   

Abstract

Proximal tubular epithelial cells (PTEC) from human renal tissue obtained from biopsy or nephrectomy were grown in monoculture and evaluated in vitro at passage 2-4 for interleukin 6 (IL-6) production in response to medium alone or to interleukin 1 alpha (IL-1 alpha), tumour necrosis factor alpha (TNF alpha), interleukin 2 (IL-2), interferon gamma (INF gamma) or lipopolysaccharide (LPS). IL-6 bioactivity was quantitated using the IL-6-dependent murine hybridoma cell line (B9) and expressed as IL-6 units/ml/10(5) PTEC. PTEC cell lines exposed to medium alone produced intermediate amounts of IL-6 with substantial variability between cell lines. Introduction of IL-1 alpha resulted in a dose- and time-dependent increase in IL-6 production by PTEC that was maximal at 1 ng/ml IL-1 alpha at 24 h. All PTEC cell lines showed an increased IL-6 production on exposure to IL-1 alpha varying from 1.3- to 24-fold increase over baseline production. This response was completely blocked by anti-rIL-1 alpha. No significant IL-6 production by PTEC could be induced by TNF alpha, IL-2, IFN gamma, or LPS over a broad dosage range. Cycloheximide inhibited IL-6 production without irreversible cell toxicity, indicating de-novo synthesis. IL-6 produced by PTEC had a molecular weight of 26-29 kDa as demonstrated by Western blot analysis. Using PCR analysis we could demonstrate upregulation by IL-1 alpha of IL-6 mRNA in a dose-response fashion, indicating that IL-1 alpha regulates IL-6 production at a pretranslational value of protein synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970084     DOI: 10.1093/ndt/9.6.599

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells.

Authors:  Ke Li; Dehuang Guo; Haidong Zhu; Kathleen S Hering-Smith; L Lee Hamm; Jingping Ouyang; Yanbin Dong
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-26       Impact factor: 3.619

2.  Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease.

Authors:  Akito Maeshima; Masao Nakasatomi; Daizo Henmi; Shin Yamashita; Yoriaki Kaneko; Takashi Kuroiwa; Keiju Hiromura; Yoshihisa Nojima
Journal:  CEN Case Rep       Date:  2012-03-17

Review 3.  Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.

Authors:  Paolo C Colombo; Anjali Ganda; Jeffrey Lin; Duygu Onat; Ante Harxhi; Julia E Iyasere; Nir Uriel; Gad Cotter
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

4.  Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.

Authors:  Jaklien C Leemans; Geurt Stokman; Nike Claessen; Kasper M Rouschop; Gwendoline J D Teske; Carsten J Kirschning; Shizuo Akira; Tom van der Poll; Jan J Weening; Sandrine Florquin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

5.  Dexamethasone prodrug treatment prevents nephritis in lupus-prone (NZB × NZW)F1 mice without causing systemic side effects.

Authors:  Fang Yuan; Richard K Nelson; Dana E Tabor; Yijia Zhang; Mohammed P Akhter; Karen A Gould; Dong Wang
Journal:  Arthritis Rheum       Date:  2012-12

6.  Stem cells: the next therapeutic frontier.

Authors:  H David Humes
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

7.  Achievements and challenges in bioartificial kidney development.

Authors:  Farah Tasnim; Rensheng Deng; Min Hu; Sean Liour; Yao Li; Ming Ni; Jackie Y Ying; Daniele Zink
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-10

Review 8.  IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target.

Authors:  Tian-Yu Lin; Yu-Hsiang Hsu
Journal:  Int J Mol Sci       Date:  2020-02-03       Impact factor: 5.923

9.  A novel design of bioartificial kidneys with improved cell performance and haemocompatibility.

Authors:  Zay Yar Oo; Karthikeyan Kandasamy; Farah Tasnim; Daniele Zink
Journal:  J Cell Mol Med       Date:  2013-03-11       Impact factor: 5.310

Review 10.  Biological Role, Mechanism of Action and the Importance of Interleukins in Kidney Diseases.

Authors:  Paulina Mertowska; Sebastian Mertowski; Iwona Smarz-Widelska; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.